What is Psoriasis-Ltd?
Treatment options for psoriasis have come a long way. The treatment of psoriasis is based on the sufferer’s age, the severity of their condition, and the type of psoriasis they have. Psoriasis tends to flare-up when the person is exposed to certain trigger factors. Substances or conditions that can worsen psoriasis include changes in climate, infections, stress, and dry skin. Also, certain medicines may cause an outbreak or worsening of the disease.
Psoriasis treatment research indicates that ocular symptoms may occur in approximately 10% of patients. Ocular involvement is more common in men than in women. It is rare to have symptoms of ocular involvement prior to skin involvement of psoriasis. Ocular psoriasis can cause symptoms including inflammation of the eye, dryness and discomfort. When psoriasis affects the eyelids, scales may cover lashes. The edges of the eyelids may become red and crusty. If inflamed for long periods, the rims of the lids may turn up or down. If the rim turns down, lashes can rub against the eyeball and cause irritation. In a prolonged ocular episode vision impairment may occur. Ocular psoriasis treatment is aimed at preventing irritation and controlling inflammation.
A team of Psoriasis Treatment Researchers with 32 years of combined research experience developed Psoriasis-Ltd. Psoriasis-Ltd was first marketed in 2001, and its parent company, Bass & Boney, Inc. has been in business since 1983. Psoriasis-Ltd has medical patents throughout the world.

<< Home